Sign in to continue:

Wednesday, March 25th, 2026

FOXO Technologies Inc. Files 8-K with SEC Announcing Executive Changes and Company Details (March 2026)





FOXO Technologies Inc. 8-K Filing Detailed Report

FOXO Technologies Inc. Announces Significant Executive Changes and Reaffirms Commitment to Internal Controls

Key Highlights from the Latest 8-K Filing

  • New Appointment: On March 24, 2026, FOXO Technologies Inc. announced the appointment of Celene Laurene Rattray Grant (age 44) as the Company’s new Financial Officer (Principal Financial and Accounting Officer).
  • Resignation: The filing references the resignation of the previous financial officer, Hauman, and notes the company’s belief that internal controls, reporting processes, and staffing have been significantly improved under current management.
  • Compensation Package: Ms. Grant will receive an annual base salary of \$200,000 and will be eligible for a discretionary annual bonus of up to \$25,000.
  • Internal Controls: Management explicitly states its commitment to maintaining strong internal controls and timely reporting, emphasizing the intended timely filing of the upcoming 10-K report.
  • No Related Transactions: The company confirms there are no transactions between Ms. Grant and FOXO Technologies Inc. requiring disclosure under Item 404(a) of Regulation S-K.
  • Emerging Growth Company: FOXO Technologies Inc. identifies itself as an “emerging growth company” and indicates it has not elected to use the extended transition period for complying with new or revised financial accounting standards.
  • Shareholder Disclosures: The filing contains no written communications, soliciting materials, or pre-commencement tender offer communications under relevant SEC rules, minimizing possible regulatory risk or litigation triggers at this time.
  • Trading & Registration: There are no securities registered pursuant to Section 12(b) of the Act and no trading symbol disclosed; the company’s shares are not currently listed on any exchange.

Details Investors Should Know

The appointment of a new Principal Financial and Accounting Officer is a material event for shareholders, especially given the explicit focus by management on improved internal controls and timely reporting. FOXO Technologies Inc. had faced prior concerns regarding its internal controls, but the filing asserts these have been “significantly improved” under current management. This, along with a commitment to timely SEC filings, could have a positive impact on investor confidence and future share value.

The compensation details for Ms. Grant indicate a competitive package, suggesting the company is investing in experienced leadership. Her appointment may also reflect a strategic move to strengthen accounting and financial functions, potentially enhancing transparency and governance.

The company’s status as an emerging growth company means certain regulatory exemptions apply, which could influence cost structures and financial disclosures. However, FOXO has opted not to use the extended transition period for new accounting standards, implying a commitment to stay current with financial reporting requirements.

There are no reportable related-party transactions, which is positive from a governance perspective. Additionally, the lack of registered securities or trading symbols means FOXO’s shares are not currently exchange-listed, an important consideration for liquidity and valuation.

The absence of written, soliciting, or tender offer communications minimizes legal and regulatory risks at this time. Investors should monitor the upcoming 10-K filing for further insights into the company’s operational and financial improvements.

Potential Share Price Impact

The combination of new executive leadership, improved internal controls, and a public commitment to timely reporting are material developments that could influence FOXO Technologies Inc.’s share value, particularly if the market perceives these changes as addressing past weaknesses and signaling future growth. Investors should be alert to the upcoming 10-K filing, which will provide more concrete evidence of the company’s financial health and governance improvements.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisors before making any investment decisions based on this information. The content is based on the publicly available SEC filing and may not reflect all material events or risks relevant to FOXO Technologies Inc.




View FOXO TECHNOLOGIES INC. Historical chart here



United Natural Foods, Inc. Q2 FY26 Earnings: Increased Profitability and Free Cash Flow Amid Lower Net Sales

United Natural Foods, Inc. Q2 FY2026 Earnings Report: Detail...

Tenaya Therapeutics: Advancing Genetic Medicines and Small Molecule Therapies for Heart Disease Treatment

Tenaya Therapeutics, Inc. 2025 Annual Report – Investor Anal...

Comstock Holding Companies, Inc. Announces Executive Retirement in SEC Form 8-K Filing

Comstock Holding Companies, Inc. - Board Change and Director...

   Ad